Obstetrics & Gynecology Science is a premier journal in the field of obstetrics and gynecology, published by the Korean Society of Obstetrics and Gynecology (KSOG). With an ISSN of 2287-8572 and an E-ISSN of 2287-8580, this journal has established a solid reputation for disseminating high-quality research since its transition to an Open Access model in 2010. Situated in South Korea, the journal contributes significantly to the global academic discourse, evidenced by its categorization in Q2 for Obstetrics and Gynecology as of 2023, and its notable Scopus ranking of #75 out of 209 in the Medicine category, reflecting a commendable 64th percentile ranking. The scope of the journal covers diverse research areas relevant to both established practitioners and emerging scholars, aiming to foster innovation and knowledge transfer in women's health. As the journal converges its focus from 2017 to 2024, it continues to be an essential resource for researchers, healthcare professionals, and students dedicated to advancing their understanding and practice in this vital field of medicine.

Welcome to the Journal of Obstetrics and Gynaecology, a premier academic publication dedicated to advancing the field of obstetrics and gynecology. Published by Taylor & Francis Inc, this esteemed journal has been a vital resource since its inception in 1945, with a convergence period from 1980 to 2024. Now embracing the Open Access model since 2023, it aims to disseminate research more broadly, facilitating knowledge transfer among researchers, healthcare professionals, and students alike. With a current impact factor that situates it within the Q3 category of Obstetrics and Gynecology, the journal has garnered recognition as a significant contributor to the medical community, ranked #109 out of 209 in Scopus. Based in the United Kingdom, the journal focuses on publishing high-quality research that addresses contemporary issues in women's health, aiming to significantly enhance clinical practices and patient outcomes. Whether you are a seasoned researcher or a student venturing into the field, the Journal of Obstetrics and Gynaecology offers a wealth of knowledge, fostering innovation and excellence within this critical discipline.

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

Revista Brasileira de Ginecologia e Obstetricia is a renowned academic journal based in Brazil, published by GEORG THIEME VERLAG KG, dedicated to advancing research in the fields of gynecology and obstetrics. With an Open Access policy since 1998, this journal ensures that critical findings and insights remain accessible to a global audience, fostering collaboration and knowledge sharing among healthcare professionals and researchers. The journal has maintained a respectable position within its field, currently ranked Q3 in Obstetrics and Gynecology according to the 2023 category quartiles, and holds a Scopus rank of 122 out of 209, placing it in the 41st percentile. Covering a wide array of topics pertinent to women's health, the Revista Brasileira de Ginecologia e Obstetricia serves as a vital platform for disseminating new research, clinical practices, and reviews, contributing to the enhanced understanding and treatment of gynecological and obstetrical conditions. The journal not only supports academic rigor but also empowers professionals and students in their pursuit of excellence in women's health.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.

The American Journal of Obstetrics and Gynecology, established in 1920 and published by Mosby-Elsevier, stands as a premier platform for the dissemination of critical research in the field of obstetrics and gynecology. With an impressive Scopus rank of #2 out of 209 journals in its category, placing it in the 99th percentile, this journal is recognized for its significant contributions to clinical practice and academia, as evidenced by its Q1 quartile status for 2023. Aimed at researchers, healthcare professionals, and students, the journal features a wide array of articles addressing contemporary issues, innovative research findings, and evolving practices in women's health and reproductive medicine. Although it does not currently offer open access options, it remains a vital resource for those seeking in-depth analysis and insights within this crucial medical specialty. By bridging the gap between research and clinical implementation, the American Journal of Obstetrics and Gynecology continues to play a pivotal role in shaping the future of obstetric and gynecologic care.

Reproduction, Fertility and Development, published by CSIRO Publishing, is a prestigious journal that has been at the forefront of research in the fields of reproductive science, developmental biology, and related disciplines since its inception in 1989. With an ISSN of 1031-3613 and an E-ISSN of 1448-5990, this journal serves as a vital platform for disseminating innovative findings and methodologies that advance our understanding of reproductive processes and development in a variety of organisms. The journal is indexed in prominent databases, exhibiting a solid standing with a Q3 quartile ranking in both Animal Science and Zoology and Biotechnology, and covering 2023 rankings in multiple related categories. Operating from Australia, Reproduction, Fertility and Development embraces a commitment to enriching scholarly communication and fostering collaborative research efforts. Its focus on high-quality, peer-reviewed articles makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest advancements and pivotal discussions in reproductive medicine and developmental biology.

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

SEMINARS IN REPRODUCTIVE MEDICINE is a leading peer-reviewed journal dedicated to exploring the complexities of human reproduction, offering insightful perspectives that encompass advances in reproductive endocrinology, obstetrics, and gynecology. Published by THIEME MEDICAL PUBL INC, this esteemed journal holds a notable spot in multiple Scopus categories, ranking 21st in Reproductive Medicine and 38th in Obstetrics and Gynecology, with an impressive impact in the Q1 and Q2 quartiles. With its commitment to high-quality research and clinical implications, the journal serves as a vital resource for practitioners, researchers, and students alike, fostering an environment of innovation and collaboration in the rapidly evolving reproductive health landscape. SEMINARS IN REPRODUCTIVE MEDICINE also offers convenient open access options, ensuring that its contributions are readily available to the global academic community. For over two decades, from its establishment in 1999 to the present, it has retained a pivotal role in disseminating critical findings that inform both clinical practice and future research efforts.